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Abstract the MHC class I chain-related protein A (MICA) is an inducible molecule almost not expressed by
 normal cells but strongly up-regulated in tumor cells. MICA-expressing cells are recognized by 
natural killer (NK) cells, CD8+ abtCr and gdtCr t lymphocytes through the NKg2D receptor. Engagement of 
NKg2D by MICA triggers IFN-g secretion and cytotoxicity against malignant cells. Although most solid tumors 
express MICA and this molecule is a target during immune surveillance against tumors, it has been observed 
that high grade tumors from different histotypes express low amounts of cell surface MICA due to a metallo-
protease-induced shedding. Also, melanomas develop after a complex process of neotransformation of normal 
melanocytes. However, the expression of MICA in premalignant stages (primary human quiescent melanocytic 
nevi) remains unknown. Here, we assessed expression of MICA by flow cytometry using cell suspensions from 
15 primary nevi isolated from 11 patients. When collected material was abundant, cell lysates were prepared 
and MICA expression was also analyzed by Western blot. We observed that MICA was undetectable in the 15 
primary nevi (intradermic, junction, mixed, lentigo and congenital samples) as well as in normal skin, benign 
lesions (seborrheic keratosis), premalignant lesions (actinic keratosis) and benign basocellular cancer. Con-
versely, a primary recently diagnosed melanoma showed intense cell surface MICA. We conclude that the onset 
of MICA expression is a tightly regulated process that occurs after melanocytes trespass the stage of malignant 
transformation. thus, analysis of MICA expression in tissue sections of skin samples may constitute a useful 
marker to differentiate between benign and malignant nevi.
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Resumen Los nevos melanocíticos premalignos quiescentes no expresan la molécula MHC class I chain-re-
 lated protein A. MHC class I chain-related protein A (MICA) es una molécula casi ausente en 
células normales pero sobre-expresada por células tumorales, que promueve el reconocimiento por células 
citotóxicas naturales (natural killer o NK) y por linfocitos t CD8+ ab y gd a través del receptor NKg2D, lo que 
dispara la secreción de IFN-g y la citotoxicidad contra las células malignas. Aunque la mayoría de los tumores 
sólidos expresan MICA y esta molécula constituye un blanco durante la inmunovigilancia contra tumores, tumores 
de alto grado expresan bajos niveles de MICA en superficie celular debido al clivaje inducido por metalopro-
teasas. Asimismo, los melanomas se desarrollan luego de la neotransformación maligna de melanocitos. sin 
embargo, se desconoce la expresión de MICA en estadios premalignos (nevos melanocíticos). En este trabajo 
analizamos la expresión de MICA en 19 nevos primarios de 11 pacientes mediante citometría de flujo. Cuando 
el material fue suficiente, también analizamos la expresión de MICA por Western blot. En ninguno de los 15 
nevos primarios (intradérmicos, junction, mixtos, lentigo y congénitos) ni en muestras de piel normal, lesiones 
benignas (queratosis seborreica), premalignas (queratosis actínica) y cáncer benigno basocelular, detectamos 
expresión de MICA. Contrariamente, un melanoma primario de diagnóstico reciente mostró intensa expresión 
de MICA en superficie celular. Nuestros resultados indican que el inicio de la expresión de MICA ocurre una 
vez que la célula ha traspasado el estadio de transformación maligna, por lo que el análisis de su expresión en 
secciones de piel podría constituir un marcador útil para diferenciar nevos benignos de melanomas malignos.
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Neoplastic transformation is the result of the accu-
mulation of a minimal number of mutations in normal 
cells that confer loss of cell cycle control, resistance to 
apoptosis, self-perpetuation capacity. In some cases, 
these tumor cells also acquire the ability to invade distant 
tissues (metastasis). this complex process occurs in im-
munocompetent hosts where the immune system sculpts 
the tumor phenotype due to the immunological pressure 
exerted on the tumor cells1. Cytotoxic cells such as natural 
killer (NK) cells, CD8+ abtCr and gdtCr t lymphocytes 
critically contribute to anti-tumor immunity in part due to 
expression of the NKg2D receptor2. Different ligands for 
NKg2D (NKg2Dls) have been described in humans, such 
as the MHC class I chain-related proteins A and B (MICA 
and B), the glycosylphosphatidylinositol (gPI)-bound 
surface molecules ul16 binding protein (ulBP)-1, -2 and 
-3, and the retinoic acid early inducible gene transcripts 
(raet)-1E and g3. Many NKg2Dls are expressed on 
tumor cells of different origins4. In particular, MICA has 
been detected in melanoma cells5. Expression of some 
NKG2DLs is induced by the DNA damage response6 and 
other oncogenic pathways that are constitutively active in 
tumor cells7-9. Also, MICA expression is regulated by NF-
kB10. However, high grade malignant tumors express less 
MICA than low grade tumors11 which is due to proteolytic 
shedding driven by tumor-secreted metalloproteases12, 13. 
It has been observed that malignant melanomas, which 
arise from neotransformed melanocytes, usually express 
MICA5, 14. However, benign nevi (junctional, compound, 
and intradermal nevi) retain melanin and form nests of 
cells that occasionally progress to malign melanomas but 
the expression of MICA in these preneoplastic lesions re-
mains unknown. therefore, we addressed the expression 
of this NKg2Dl in 19 samples from benign quiescent nevi 
obtained from 11 patients. the characteristics of these 
nevi are given in table 1. Also, one sample of a patient 
with malignant melanoma (grade II/III) was obtained at 
the moment of diagnosis. Procedures were followed in 
accordance with the Declaration of Helsinki and had the 
approval by the Institutional Ethical Committee (Hospital 
de Clínicas). Written informed consent was obtained 
from each patient. Patients were selected according to 
the clinical diagnosis. Dermatoscopic analysis confirmed 
that the biopsed sample was a benign quiescent nevus. 
Briefly, 3 mm diameter punches were obtained from skin 
with nevi. samples were divided in two. one part was 
used for the confirmation of the diagnosis by the patho-
logist. the other was used for the preparation of single 
cell suspensions by mechanical disruption of the tissue 
samples, and processed for flow cytometry analysis. 
When a sufficient number of cells were recovered, cell 
lysates were also obtained for sDs-PAgE and Western 
blot analysis. Also, the human melanoma cell lines IIB-
MEl-IAN and A375N were used14. Cells were cultured in 
10% fetal bovine serum (NatoCor, Córdoba, Argentina) 
in Dulbecco´s modified Eagle´s medium (DMEM, Sigma), 
supplemented with sodium pyruvate, glutamine, and an-
tibiotics (all from sigma).
Expression of cell surface MICA was analyzed by 
flow cytometry (FC) with the anti-MICA/B mAb D714 and 
PE-labeled anti-mouse Igg (DAKo) in a FACscalibur 
flow cytometer (BD). Specific fluorescence index (SFI) 
was calculated as the mean fluorescence produced by 
the D7 mAb divided by the mean fluorescence produced 
by the IC mAb. sDs-PAgE of cell lysates and Western 
blot were performed using anti-MICA polyclonal Ab, as 
described14. Bound Ab were detected using HrP-labeled 
anti-rabbit Igg (Bio-rad) and chemiluminescence. No 
bands were observed in Western blots incubated with 
normal rabbit Igg.
First, we analyzed cell suspensions of the nevi obtained 
from patients enrolled in this study for cell surface expres-
sion of MICA. We observed that none of the 15 samples 
of primary nevi (intradermic, junction, mixed, lentigo and 
congenital samples) as well as in normal skin, benign le-
sions (seborrheic keratosis), premalignant lesions (actinic 
keratosis) and benign basocellular cancer derived from 
11 different patients showed staining with the anti-MICA/B 
mAb D7. representative staining patterns from 2 different 
samples are shown in Fig. 1A. Conversely, one freshly 
isolated melanoma and the IIB-MEl-IAN cell line, which is 
known to express cell surface MICA, (14), showed intense 
staining, as shown in Fig. 1B.




 Intradermic cellular nevus
 Actinic keratosis
lM verrucous nevus
 Intradermic cellular nevus
 Intradermic cellular nevus
JC Junction nevus
 lentigo
tA Intradermic cellular nevus
Hl Mixed cellular nevus
Cg Intradermic cellular nevus
 Intradermic cellular nevus
 Intradermic cellular nevus
Cr Intradermic cellular nevus
Hg Intradermic cellular nevus
EP Intradermic cellular nevus
ls Intradermic cellular nevus
NM Congenic melanocytic nevuswith sclerodermiform halus
Fr Congenic melanocytic nevuswith nodular melanoma
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Previously, in our laboratory we described a novel tu-
mor immune escape mechanism based on an intracellular 
retention of immature forms of the MICA polypeptide which 
conferred immune privilege to some human melanoma 
cells14. to investigate whether similar intracellular pool of 
MICA may exist in benign nevi, in cases in which we had 
sufficient number of cells in order to run flow cytometry 
experiments and prepare cell lysates, MICA expression 
was also analyzed by Western blot (Fig. 1C). Again, we 
were unable to detect MICA in benign quiescent nevi. In 
contrast, cell lysates of IIB-MEl-IAN and A375N mela-
noma cell lines exhibited easily detectable amounts of 
MICA. these results indicate that benign quiescent nevi, 
in opposition to malign melanomas, do not express cell 
surface MICA.
Although one of the most important differences 
between benign nevi and melanomas is the ability of 
melanomas to proliferate without control and eventua-
lly metastasize, it is sometimes difficult to distinguish 
between benign and malign melanocytes15. Also, the 
presence of infiltrating CD8+ and NK cells in benign nevi 
is not strictly and systematically associated with a benign 
or malign diagnosis. thus, correct diagnosis remains 
uncertain in some cases. In our study, we established 
that expression of MICA was restricted to malign neo-
transformed melanocytes (melanomas). since benign 
quiescent melanocytic nevi did not express MICA on their 
cell surface or as intracellular deposits, we believe that 
neo-expression of MICA is an event that takes place after 
the cell achieved malign transformation into a melanoma, 
a characteristic that would put it under the scrutiny of 
NKg2D-expressing cells. such critical point would take 
place once the melanocyte turned on a transcriptional 
program and a DNA damage response that would be 
one of the first steps contributing to the acquisition of the 
malignant phenotype. Assessment of MICA expression 
may therefore contribute to the differential diagnosis of 
benign nevi vs. malign melanomas.
In summary, the results here described represent the 
first analysis of expression of MICA in benign melanocytic 
nevi and lead to the conclusion that the onset of MICA 
expression is a tightly regulated process that occurs after 
melanocytes have trespassed the stage of malignant 
transformation. therefore, analysis of MICA expression in 
tissue sections of skin samples may constitute a marker to 
differentiate between benign and malignant nevi.
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- - - -
Salgo de Estados-Unidos, mi estimado amigo, en aquel estado de excitación que causa 
el espectáculo de un drama nuevo, lleno de peripecias, sin plan, sin unidad, erizado de crí-
menes que alumbran con su luz siniestra actos de heroísmo i abnegación, en medio de los 
esplendores fabulosos de decoraciones que remedan bosques seculares, praderas floridas, 
montañas sañudas, o habitaciones humanas en cuyo pacífico recinto, reinan la virtud i la 
inocencia. Quiero decirle que salgo triste, pensativo, complacido i abismado; la mitad de mis 
ilusiones rotas o ajadas, miéntras que otras luchan con el raciocinio para decorar de nuevo 
aquel panorama imaginario en que encerramos siempre las ideas cuando se refieren a objetos 
que no hemos visto, como damos una fisonomía i un metal de voz al amigo que solo por carta 
conocemos. Los Estados-Unidos son una cosa sin modelo anterior, una especie de disparate 
que choca a la primera vista, i frustra la expectación, pugnando con las ideas recibidas, i no 
obstante este disparate inconcebible es grande i noble, sublime a veces, regular siempre; i 
con tales muestras de permanencia i de fuerza orgánica se presenta, que el ridículo se des-
lizaría sobre su superficie como la impotente bala sobre las duras escamas del caiman.[…]
Domingo Faustino sarmiento (1811-1888)
Viajes por Europa, Africa y América 1845-1847 y Diario de gastos. Edición crítica de Javier 
Fernández (Coordinador). Buenos Aires: AllCA xx-FCE Argentina, 1993.
Carta al sr. Don valentin Alsina. Noviembre 12 de 1847. p 290. grafía original conservada.
